Presence of oncogenic HPV DNAs in cervical carcinoma tissues and pelvic lymph nodes associating with proliferating cell nuclear antigen expression

Gynecologic Oncology

Volumn 60, Issue 3, 1996, Pages 418-423

  Park, Jong Sup ^a,b,c   Rhyu, Ki Sung ^a   Kim, Chan Joo ^a   Kim, Hy Sook ^b   Han, Ku Taek ^a   Ahn, Hee Kyoung ^a   Kim, Seung Jo ^a   Namkoong, Sung Eun ^a,b  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Cheil General Hospital   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; VIRUS DNA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FEMALE GENITAL TRACT INFECTION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PELVIS LYMPH NODE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

EID: 0343985349     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0066     Document Type: Article

References (28)

1. zur Hausen, H., and Schneider, A. The role of papillomaviruses in human anogenital cancer, in The papovaviridae: The papillomaviruses (N. P. Salzmann and P. M. Howley, Eds.), Plenum, New York, Vol. 2, pp. 1014-1019 (1987).
2. Wilczynski, S. P., Bergen, S., Walker, J., Liao, S. Y., and Pearlman, L. F. Human papillomaviruses and cervical cancer: Analysis of histologic features associated with different viral types, Hum. Pathol. 19, 697-704 (1988).
3. Claas, E. C. J., Melchers, W. J. G., van der Linden, H. C., Linderman, J., and Quint, W. G. V. Human papillomavirus detection in paraffin-embedded cervical carcinomas and metastases of the carcinomas by the polymerase chain reaction, Am. J. Pathol. 135, 703-709 (1989).
4. Czegledy, J., Poka, R., Veress, G., and Gergely, L. Amplification of human papillomavirus type 16 transforming genes from cervical cancer biopsies and lymph nodes of Hungarian patients, J. Clin. Microbiol. 30, 233-236 (1992).
5. Ikenberg, H., Teufel, G., Schmott, B., Kommoss, F., Stanimirovic, B., and Pfleiderer, A. Human papillomavirus DNA in distant metastases of cervical cancer, Gynecol. Oncol. 48, 56-60 (1993).
6. Fuchs, P. G., Girardi, F., and Pfister, H. Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: A diagnostic marker for early metastasis? Int. J. Cancer 43, 41-44 (1989).
7. Park, J. S., Chee, Y. H., Namkoong, S. E., Han, S. K., Kim, T. E., Lee, H. Y., and Kim, S. J. Human papillomavirus detection in cervical carcinoma tissues and paraaortic lymph nodes by the polymerase chain reaction, Gynecol. Oncol. 53, 344-351 (1994).
8. Dyson, N., Howley, P. M., Munger, K., and Harlow, E. The human papillomavirus-16 E7 oncoprotein is able to bind retinoblastoma gene product, Science 243, 934-937 (1989).
9. Werness, B. A., Levine, A. J., and Howley, P. M. Association of human papillomavirus type 16 and 18 E6 proteins with p53, Science 248, 76-79 (1990).
10. Durst, M., Dzarlieva-Petrusevska, R. T., Boukamp, P., Fusenig, N E., and Gissmann, L. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA, Oncogene 1, 251-256 (1987).
11. Merrick, D. T., Blanton, R. A., Gown, A. M., and McDougall, J. K. Altered expression of proliferation and differentiation markers in human papillomavirus 16 and 18 immortalized epithelial cells grown in organotypic culture, Am. J. Pathol. 140, 167-177 (1992).
12. El-Deiry, W. S., Tokino, T., Velculescu, V. E., et al. WAF1, a potential mediator of p53 tumor suppression, Cell 75, 817-825 (1993).
13. Mayer, A., Takimoto, M., Fritzo, E., et al. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor and mdr gene expression in colorectal cancer, Cancer 71, 2454-2460 (1993).
14. Waga, S., Hannon, G. J., Beach, D., and Stillman, B. The p21 inhibitor of cyclin-dependent kinase controls DNA replication by interaction with PCNA, Nature 369, 574-578 (1994).
15. Saiki, R. K., Bugawa, T. L., Horn, G. T., and Erlich, H. A. Analysis of enzymatically amplified beta-globin and HLA-DQ-alpha DNA with allele-specific oligonucleotide probes, Nature 324, 163-166 (1986).
16. Hall, P. A., Levison, D. A., Woods, A. L., et al. Proliferation cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms, J. Pathol. 162, 285-294 (1990).
17. Reid, R., Greenberg, M., Jensen, A. B., et al. Sexually transmitted papillomavirus infections. I. The anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types, Am. J. Obstet. Gynecol. 156, 212-222 (1987).
18. Lorincz, A. T., Reid, R., Jensen, A. B., Greenberg, M. D., Lancaster, W., and Kurman, R. J. Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types, Obstet. Gynecol. 79, 328-337.
19. Fuchs, P. G., Girardi, F., and Pfister, H. Human papillomavirus DNA in normal, metaplastic, preneoplastic and neoplastic epithelia of the cervix uteri, Int. J. Cancer 41, 41-45 (1988).
20. Lancaster, W. D., Castellano, C., Santos, C., Delgado, G., Kurman, R. J., and Jensen, A. B. Human papillomavirus deoxyribonucleic acid in cervical carcinoma from primary and metastatic sites, Am. J. Obstet. Gynecol. 154, 115-119 (1986).
21. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53, Cell 63, 1129-1136 (1990).
22. Lane, D. P. Cancer. A death in the life of p53, Nature 362, 786-787 (1993).
23. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 cdk-interacting protein cipl is a potent inhibitor of G1 cyclin dependent kinases, Cell 75, 805-816 (1993).
24. Porter, P. L., Gown, A. M., Kramp, S. G., and Coltrera, M. D. Widespread p53 expression in human malignant tumors, Am. J. Pathol. 140, 145-153 (1992).
25. Marks, J. R., Davidoff, A. M., and Kerns, B. J. Overexpression and mutations of p53 in epithelial ovarian cancer, Cancer Res. 51, 2979-2984 (1991).
26. Crook, T., Wrede, D., and Vousden, K. H. p53 mutation in HPV negative human cervical carcinoma cell lines, Oncogene 6, 873-875 (1991).
27. Crook, T., Wrede, D., Tidy, J. A., Mason, W. P., Evans, D. J., and Vousden, K. H. Clonal p53 mutation in primary cervical cancer: Association with human papillomavirus negative tumors, Lancet 339, 1070-1073 (1992).
28. Crook, T., and Vousden, K. H. Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens, EMBO J. 11, 3935-3940 (1992).